What is the story about?
Zomato founder Deepinder Goyal announced on Tuesday, May 5, that the first 100 units of his much-anticipated wearable device, Temple, are ready for shipment, inviting users to apply for early access.
In a post on X, Goyal said the company is opening its initial cohort to “athletes, scientists, founders, doctors, creators, and individuals who care deeply about their physical and cognitive health,” calling them the founding users of the product.
Temple is being positioned as a next-generation wearable focused on tracking both physical and cognitive performance. According to its website, the device is worn on the temple region of the head, where biological signals such as blood flow and skin regulation can be captured more accurately due to thin tissue and dense vascular structures.
Also read: Who is Claire Mazumdar? The niece set to succeed Biocon’s Kiran Mazumdar-Shaw
The company describes the product as a “precision instrument” designed to optimise training, recovery, work and sleep, while offering deeper insights into human physiology compared to conventional wearables.
The latest announcement builds on Goyal’s teaser earlier this year, when he described Temple as “the most important wearable ever made” and revealed that he had been personally testing the device for over a year.
At the time, the company had hinted at opening a waitlist, with early visuals showing a compact device placed near the temple on the forehead.
The wearable is also linked to Goyal’s “Gravity Ageing Hypothesis” research, which explores monitoring blood flow and brain health. Temple aims to move beyond traditional wrist-based trackers by delivering a more comprehensive, “head-to-toe” view of health within a single ecosystem.
While detailed specifications and pricing remain undisclosed, the early access rollout marks the first step towards a broader launch of the device.
In a post on X, Goyal said the company is opening its initial cohort to “athletes, scientists, founders, doctors, creators, and individuals who care deeply about their physical and cognitive health,” calling them the founding users of the product.
Temple is being positioned as a next-generation wearable focused on tracking both physical and cognitive performance. According to its website, the device is worn on the temple region of the head, where biological signals such as blood flow and skin regulation can be captured more accurately due to thin tissue and dense vascular structures.
Also read: Who is Claire Mazumdar? The niece set to succeed Biocon’s Kiran Mazumdar-Shaw
The company describes the product as a “precision instrument” designed to optimise training, recovery, work and sleep, while offering deeper insights into human physiology compared to conventional wearables.
The latest announcement builds on Goyal’s teaser earlier this year, when he described Temple as “the most important wearable ever made” and revealed that he had been personally testing the device for over a year.
At the time, the company had hinted at opening a waitlist, with early visuals showing a compact device placed near the temple on the forehead.
The wearable is also linked to Goyal’s “Gravity Ageing Hypothesis” research, which explores monitoring blood flow and brain health. Temple aims to move beyond traditional wrist-based trackers by delivering a more comprehensive, “head-to-toe” view of health within a single ecosystem.
While detailed specifications and pricing remain undisclosed, the early access rollout marks the first step towards a broader launch of the device.




/images/ppid_59c68470-image-177796521521553134.webp)
/images/ppid_59c68470-image-177796252712882509.webp)
/images/ppid_a911dc6a-image-177796506908199341.webp)
/images/ppid_a911dc6a-image-177796852559228501.webp)
/images/ppid_a911dc6a-image-177789156664845982.webp)
/images/ppid_59c68470-image-177797256667743435.webp)

/images/ppid_59c68470-image-177797752645616533.webp)
